2. As one of CEPI’s longest-standing and largest funders, Germany’s renewed commitment recognises that global cooperation, scientific excellence and solidarity are our best defences against future health crises.

1. 📢Germany reaffirms its global health leadership with a EUR 100M pledge to CEPI. This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all. @bmftr_bund cepi.net/bmftr-boosts-intern…

Honored to share that Germany has renewed its longstanding commitment to and partnership with CEPI, with a new EUR 100 million pledge to support our critical work over the next five years. Germany’s renewed commitment to CEPI reflects true global leadership at a time when its importance could not be greater. The country’s sustained investment in CEPI recognizes that science and solidarity are essential if we are to defend all nations against epidemic and pandemic threats. I am grateful for Germany’s powerful endorsement of CEPI’s critical role in making the world a safer place for all. The threat of epidemics and pandemics hasn’t gone away; indeed, climate change, global travel and urbanization are only exacerbating the risk. That’s why continued investment in preparedness, and continued investment in CEPI, are more crucial than ever to our collective global health security. Herzlichen Dank, Deutschland! @bmftr_bund Learn more here ➡️cepi.net/bmftr-boosts-intern…

Happening now: #G20 Health Working Group meetings. 📸 Opening remarks by @HealthZA & @CEPIvaccines #C20SouthAfrica

“NB.1.8.1 in particular possesses quite a few new mutations on its spike protein that make it easier to cling to human cells” star-telegram.com/news/state…

"The (U.S.) government is discarding what could be one of the most effective and rapid tools to combat an avian influenza outbreak." US cancels more than $700 million funding for Moderna bird flu vaccine reuters.com/business/healthc…

Read this article as @kkelland speaks to researchers in African countries working on clinical trials for what could be world’s first #Lassafever vaccine “Developing a vaccine against Lassa fever holds great potential for global health security extending beyond West Africa” 👇🏿

#ISNTDFestival 2025 is here and we are delighted to host our next Book Panel! Don't miss @VIhekweazu @nighealthwatch, @kkelland @cepi & @J_J_Kennedy discussing how pathogens have shaped our lives! 👉Apr 3, 10.15 UK time 👉isntd.org/isntd-festival

#Cooperazioneitaliana 🇮🇹 supports @CEPIvaccines to accellerate research and development of new vaccines against emerging infectious diseases capable of threatening global health, ensuring their accessibility in middle and low income countries.

For World Book Day why not discover how the world could face down a future Disease X threat with pandemic-busting vaccines in as few as 100 days? Get a copy of @kkelland's book, DISEASE X - The 100 Days Mission to End Pandemics, if you haven't already ⬇️ amazon.co.uk/Disease-Inside-…

GVN was honored to co-host a discussion yesterday with students & @CEPIvaccines's @kkelland at @JohnsHopkinsSPH . We explored how to prepare for the next Disease X & challenges in advancing #PandemicPreparedness & response to #endpandemics. #100DaysMission

“A bold and credible roadmap for how to be ready to better respond to future pandemic threats and, ultimately, to end pandemics," said Former British Prime Minister Tony Blair about @kkelland's book, DISEASE X – The 100 Days Mission to End Pandemics. amzn.to/4aJ3Oih

China is experiencing a surge in infections of human metapneumovirus (hMPV), which causes respiratory infections a bit like the common cold, but can also lead to bronchitis and pneumonia. Learn more about hMPV and its viral family, the Pneumoviruses, in #TheViralMostWanted ➡️ cepi.net/pneumoviruses-and-a…

🚨🚨Thailand shares 1st genome of #Mpox clade Ib collected on Asian continent 1/x The speed at which Thailand & Sweden show full transparency & collaboration w/ @GISAID for global data sharing helps to save lives Thailand's National Institute of Health @prdthailand shared data through @GISAID #EpiPox (EPI_ISL_19350788), collected from traveler from DRC 🇨🇩 8/16/2024 (🧬shared 5 days after collection, rich w/ full metadata) See GISAID.org @WHO @WHOAFRO #EPRTAG @AfricaCDC @CDCgov @mvankerkhove @JeanKaseya2 @SalamGueye @WHOSTP @PaulNuki @ReporterGoodman

How many lives did #Covid19 vaccines save? A new paper in Lancet Respiratory Medicines estimates that in Europe alone (34 countries/areas included here) about 1.6 million lives were saved by the vaccines til March 2023. thelancet.com/journals/lanre…

New mpox variant posing 'severe' risk to hundreds of thousands, experts warn David Heymann explains to @MailOnline why #mpox could "fill the epidemiological niche left by smallpox" 👇 dailymail.co.uk/health/artic…

Did you miss any of the sessions from the recent Global Pandemic Preparedness Summit 2024, or curious to hear how some of the breakout sessions unfolded? 📺 From panels and fireside chats to breakouts and short talks, watch all #GPPS2024 recordings now. vimeo.com/showcase/gpps2024

The world urgently needs a Lassa vaccine. A CEPI-funded Phase II trial of @IAVI's Lassa vaccine candidate represents “an important milestone and signals that better tools to manage and prevent outbreaks are coming.” @devex | @HJFMRI_Nigeria: devex.com/news/how-a-new-vac…

The potential human epidemic threat posed by the outbreak of #H5N1 bird flu among dairy cattle in the United States is “increasing daily”, says Dr @RickABright. For this new article, @KKelland spoke with the global flu expert at #GPPS2024 to get an understanding of just how concerning the current H5N1 outbreak is. Read the full article to learn more ➡️ bit.ly/4dtEwoe

.@CEPIvaccines & WHO call for an expansion of pandemic research 🔬: focus on families of pathogens in addition to individual disease threats. This approach boosts readiness for unforeseen outbreaks, zoonotic spill-overs, and the hypothetical threat of a ‘pathogen X’: bit.ly/3YqlX00